Literature DB >> 8104193

Interferon-gamma-inducible endothelial cell class II major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis.

L M Jemison1, S K Williams, F D Lublin, R L Knobler, R Korngold.   

Abstract

The interaction between encephalitogenic lymphocytes and the cerebral microvascular lining is considered to be an important initial step in the recruitment of immune cells into the central nervous system (CNS) under pathological conditions such as multiple sclerosis (MS) and its investigative analog, experimental allergic encephalomyelitis (EAE). This study was conducted in order to examine whether differences in microvascular endothelial cell expression of several molecules involved in lymphovascular interactions correlate with the strain and organ-specific development of EAE. Cerebral and epididymal microvascular endothelial cells (EC) were isolated from SJL and B10.S mice, which, despite MHC-compatibility (H-2S), differ in their ability to develop EAE. The subcultured cells were then analyzed by flow cytometry for their ability to express class I MHC, class II MHC and ICAM-1 molecules in response to treatment with murine recombinant interferon-gamma (IFN-gamma). Over a range of doses and times, cerebral EC cultures derived from EAE-susceptible SJL mice expressed two-fold higher levels and higher cell surface densities of class II molecules than cerebral EC cultures derived from EAE-resistant B10.S mice, whereas class I and ICAM-1 molecules were comparably upregulated on both SJL and B10.S cerebral EC. In contrast, both SJL and B10.S epididymal EC cultures expressed lower but comparable levels of class II molecules in response to IFN-gamma. Class I and ICAM-1 molecules, however, were upregulated to at least the same degree as that observed on cerebral EC derived from both strains.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104193     DOI: 10.1016/0165-5728(93)90280-c

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

Review 1.  Cytokine-induced inflammation in the central nervous system revisited.

Authors:  J A Martiney; C Cuff; M Litwak; J Berman; C F Brosnan
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 2.  B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis.

Authors:  P J Perrin; D Scott; C H June; M K Racke
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

3.  Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria.

Authors:  C Monso-Hinard; J N Lou; C Behr; P Juillard; G E Grau
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

Review 4.  The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Rebecca A Sosa; Thomas G Forsthuber
Journal:  J Interferon Cytokine Res       Date:  2011-09-15       Impact factor: 2.607

5.  Strain-specific variation in constitutive and inducible expression of MHC class II, class I and ICAM-1 on rat cerebral endothelium.

Authors:  A T Linke; D K Male
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

6.  Encephalitogenicity of murine, but not bovine, DM20 in SJL mice is due to a single amino acid difference in the immunodominant encephalitogenic epitope.

Authors:  J M Greer; C Klinguer; E Trifilieff; R A Sobel; M B Lees
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 4.414

7.  Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.

Authors:  Kerstin Berer; Marina Boziki; Gurumoorthy Krishnamoorthy
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.